Pfizer at ACT 2026
Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website
Pfizer takes part in 3 sessions at ACT 2026 in San Antonio. Its program centres on in vivo gene therapies, from new advances to regulatory roadmaps and development hurdles. It also covers a home-cage, computer vision measure of nerve damage caused by chemotherapy in rats.
| Organization | ACT 2026 Attendance |
|---|---|
Pfizer New York, NY | ◇Silver Supporter |
Global pharmaceutical company; its safety scientists present on in vivo gene therapy and chemotherapy-induced neuropathy in rats. | Session Mon Nov 16 2:00pm–5:00pm In Vivo Gene Therapies: Breakthrough Innovations, Regulatory Roadmaps, and Development Challenges (S04)
Talk Mon Nov 16 2:00pm–2:10pm |
Instantly find 20 buyers from Pfizer
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction